Smoking Cessation Facilitated by Glucagon-like Peptide-1 (GLP-1) Analogues
Clinical trial NCT03204396 · COMPLETED
Trial details
- NCT number
- NCT03204396
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-26
- Primary completion
- 2022-07-30
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.